Search
  1. Home
  2. Southern Africa
  3. South Africa
  • News

Limpopo joins national AIDS drug rollout

    JOHANNESBURG

    A long-awaited antiretroviral treatment programme has finally been launched in South Africa's Limpopo province.

    AIDS organisations expressed disappointment early in August over the delay in the rollout of anti-AIDS drugs, saying their requests for speedy drug delivery seemed to have fallen on deaf ears.

    The provincial department of health and welfare said an earlier shortage of drugs and trained staff had delayed the rollout, but eight sites were now accredited and equipped with staff qualified to treat HIV-positive people.

    The South African Broadcasting Corporation quoted provincial health MEC Seaparo Sekwati as saying: "We know the constraints that our people will face in terms of travelling distances to go for testing and therapy, and we are going to find ways and means to make sure we reduce those constraints."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join